BREAST CANCER TRIALS
Ensure Breast Cancer Trials Stay On Schedule with Biorasi
Managing breast cancer clinical studies can prove challenging to even the most established and experienced pharmaceutical company. Right from the beginning, breast cancer trials can experience recruitment obstacles due to patient perception of the study. Eligibility can prevent successful starts, with narrow exclusion criteria immediately limiting the pool of patient subjects. Additionally, many patients cite the inconveniences within the study schedule – ranging from travel to time off from work – as barriers that prevent them from enrolling.
Biorasi Keeps Your Breast Cancer Trials Moving
Biorasi is a new kind of CRO that combines oncology experience, innovative project management, and digital technology into a comprehensive solution designed to optimize your breast cancer trials:
- Biorasi can maximize your recruitment reach to ensure the right demographics and diversity within your studies.
- We also work with online communities, patient registries, and national support groups to raise awareness for breast cancer and rare oncological disease clinical trials.
- We can work with you on clinical protocols to ensure that patient subject criteria do not limit your study or negatively impact your results.
We also realize the positive impact that decentralized solutions and patient-centric strategies can have on breast cancer trials. Our digital technology offerings and patient-focused strategies are designed to improve participation, remove the travel burden, and engage patients for the long term.